Transplant-Associated Viral Infections

Solid organ and hematopoietic stem cell transplant recipients are uniquely predisposed to develop clinical illness, often with increased severity, due to a variety of common and opportunistic viruses. Patients may acquire viral infections from the donor (donor-derived infections), from reactivation of endogenous latent virus, or from the community. Herpes viruses, most notably cytomegalovirus and Epstein Barr virus, are the most common among opportunistic viral pathogens that cause infection after solid organ and hematopoietic stem cell transplantation. The polyoma BK virus causes opportunistic clinical syndromes predominantly in kidney and allogeneic hematopoietic stem cell transplant recipients. Hematopoietic stem cell transplantation is the treatment of choice for many hematologic malignancies and genetic diseases. However, viral infections continue to account for substantial post-transplant morbidity and mortality. While antiviral drugs are available against some viruses, they are associated with significant side effects and are frequently ineffective.

 

    Related Conference of Transplant-Associated Viral Infections

    June 24-25, 2019

    48th World Congress on Microbiology

    Moscow, Russia
    July 01-02, 2019

    11th International Virology Summit

    Valencia, spain
    July 26-27, 2019

    World Yeast Congress

    Vancouver | Canada
    October 21-22, 2019

    6th World Congress and Expo on Applied Microbiology

    Rome, Italy
    October 23-24, 2019

    2nd Global Experts Meeting on Chronic Diseases

    Tokyo, Japan
    November 06-07, 2019 |

    15th Global Summit on Virology and Microbiology

    Yokohama | Japan
    November 14-15, 2019

    23rd World Congress on Biotechnology

    Amsterdam, Netherlands
    December 04-05, 2019

    Orthodontics and Prosthodontics

    Tokyo, Japan

    Transplant-Associated Viral Infections Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in